These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 6781527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS.
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H, Korninger C.
    Wien Klin Wochenschr; 1983 Nov 11; 95(21):753-7. PubMed ID: 6424339
    [Abstract] [Full Text] [Related]

  • 8. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori MT, Girolami A.
    Haematologia (Budap); 1993 Nov 11; 25(1):57-67. PubMed ID: 8339998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
    Greer IA, McLaren M, Belch JJ, Lowe GD, Forbes CD.
    Haemostasis; 1986 Nov 11; 16(1):15-9. PubMed ID: 3084364
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH, Giddings JC, Bloom AL.
    Br J Haematol; 1984 Aug 11; 57(4):651-62. PubMed ID: 6430337
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
    Garcia VV, Silva IA, Borrasca AL.
    Thromb Haemost; 1982 Aug 24; 48(1):91-3. PubMed ID: 6813999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB, Crane S.
    Can J Vet Res; 1987 Apr 24; 51(2):189-93. PubMed ID: 3111674
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K, Letowska M, Sabliński J, Binder BR, Kopeć M, Lopaciuk S.
    Acta Haematol Pol; 1994 Apr 24; 25(3):261-8. PubMed ID: 7992599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.